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Background: Dobutamine associated left ventricular (LV) wall motion analyses exhibit reduced sensitivity for
detecting inducible ischemia in individuals with increased LV wall thickness. This study was performed to better
understand the mechanism of this reduced sensitivity in the elderly who often manifest increased LV wall thickness
and risk factors for coronary artery disease.
Methods: During dobutamine cardiovascular magnetic resonance (DCMR) stress testing, we assessed rate pressure
product (RPP), aortic pulse wave velocity (PWV), LV myocardial oxygen demand (pressure volume area, PVA, mass,
volumes, concentricity, and the presence of wall motion abnormalities (WMA) and first pass gadolinium enhanced
perfusion defects (PDs) indicative of ischemia in 278 consecutively recruited individuals aged 69 ± 8 years with
pre-existing or known risk factors for coronary artery disease. Each variable was assessed independently by
personnel blinded to participant identifiers and analyses of other DCMR or hemodynamic variables.
Results: Participants were 80% white, 90% hypertensive, 43% diabetic and 55% men. With dobutamine, 60% of the
participants who exhibited PDs had no inducible WMA. Among these participants, myocardial oxygen demand was
lower than that observed in those who had both wall motion and perfusion abnormalities suggestive of ischemia
(p = 0.03). Relative to those with PDs and inducible WMAs, myocardial oxygen demand remained different in these
individuals with PDs without an inducible WMA after accounting for LV afterload and contractility (p = 0.02 and 0.03
respectively), but not after accounting for either LV stress related end diastolic volume index (LV preload) or resting
concentricity (p = 0.31-0.71).
Conclusions: During dobutamine stress testing, elderly patients experience increased LV concentricity and declines
in LV preload and myocardial oxygen demand, all of which are associated with an absence of inducible LV WMAs
indicative of myocardial ischemia. These findings provide insight as to why dobutamine associated wall motion
analyses exhibit reduced sensitivity for identifying inducible ischemia in elderly.
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The presence of inducible left ventricular wall motion ab-
normalities (LVWMA) observed during dobutamine stress
echocardiography (DSE) and dobutamine cardiovascular
magnetic resonance (DCMR) is utilized widely to identify
myocardial ischemia indicative of coronary artery disease
(CAD) and forecast future cardiovascular (CV) events in
those unable to exercise [1-5]. Dobutamine stress wall
motion analyses performed with DSE or DCMR exhibit
reduced sensitivity for detecting myocardial ischemia in
those with altered left ventricular (LV) geometry due to
increased LV concentricity and hypertrophy, both com-
mon conditions in the elderly [6,7]. Dobutamine stress
myocardial perfusion analyses performed with contrast
echocardiography or cardiovascular magnetic resonance
(CMR) display improved sensitivity for identifying coron-
ary artery stenosis of intermediate severity or forecasting
prognosis regardless of ventricular shape [8-10].
In this study, we sought to understand the mechanism
by which myocardial perfusion defects occur without con-
comitant inducible LVWMA in older individuals undergo-
ing dobutamine stress testing. To accomplish this, we
performed DCMR, a procedure which allows simultan-
eous assessment of wall motion and perfusion, LV concen-
tricity, preload, afterload, and contractility in older
individuals who frequently exhibit altered LV remodeling.
Methods
Study design
The study was approved by the Institutional Review
Board of Wake Forest Health Sciences, and each partici-
pant provided witnessed written informed consent. This
study was registered within the United States on Clini-
caltrials.gov (NCT00542503) and was performed in ac-
cordance with the National Institutes of Health grants
R01HL076438 and P30AG21332. In addition, this study
complied with the Declaration of Helsinki. The purpose
of this initiative was to utilize advanced DCMR tech-
niques to identify rest and stress-induced cardiac and
vascular abnormalities in older individuals that are asso-
ciated with CV disease. In this study, each participant
underwent an interview to collect and record informa-
tion pertinent to CV disease (e.g., demographics, CV risk
factors, etc.) and then underwent DCMR in which rate
pressure product (RPP), aortic pulse wave velocity
(PWV), LV myocardial oxygen demand (pressure volume
area, PVA, stroke work, SW), mass, volumes, concentri-
city, and the presence of WMA and first pass gadolin-
ium enhanced perfusion defects (PDs) indicative of
ischemia were measured and recorded.
Study population
The study included participants from the rural counties
of Central and Western North Carolina that exhibiteda >5 years presence of risk factors (e.g., hypertension,
diabetes, or CAD) for a cardiac event, but no history of
myocardial infarction within 6 months of enrollment, no
contraindication to intravenous dobutamine or gadolin-
ium based contrast nor the performance of a CMR exam
(such as the presence of incompatible bio-metallic im-
plants or claustrophobia). None of the subjects had angina
or symptoms of heart failure in the 12 months prior to en-
rollment. Recruitment of study participants was achieved
through newspaper and television advertisements, or mail-
ings to randomly selected individuals over the age of 55,
but <85 years within Forsyth, Davie, and Davidson coun-
ties of Northwest North Carolina [4,5,11].
Wall motion imaging
The DCMR protocol was accomplished according to pre-
viously published techniques [4,5] with images that were
acquired on a 1.5-T (Siemens Avanto) whole-body im-
aging system using a phased-array cardiothoracic surface
coil placed on the chest. Dobutamine was infused incre-
mentally from low (7.5 mcg/kg/min) to peak dose (20 to
40 mcg/kg/min), along with atropine (up to 1.5 mg), to
achieve 80% of the maximum predicted heart rate re-
sponse (MPHRR) for age. Cine images of the left ventricle
were obtained in multiple contiguous short axis slices
(apex to base) and in 3 long axis views (2, 3, and 4 cham-
ber) at rest, low and peak dose dobutamine, and then after
10 minutes of recovery. Measurements of brachial artery
systolic (SBP) and diastolic blood pressure (DBP) were
performed using a CMR compatible sphygmomanometer.
According to previously published techniques [11,12], LV
volumes were measured from the short-axis series of cine
white blood imaging sequences using a modified Simpson’s
rule method [12]. LV concentricity was measured as the ra-
tio of the LV mass to the LV end-diastolic volume as de-
scribed by Chuang et al. [13]. Image acquisition parameters
included a 45 msec repetition time (TR), a 1 msec echo
time (TE), a 78° flip angle (FA), a 400 × 324 mm field of
view (FOV), a 192 × 109 matrix, and an 8 mm thick slice
with a 2 mm gap and an acceleration factor of 2 [5].
Wall motion (WM) analysis
The LV wall motion at rest, peak dose and in recovery was
assessed with a visual scoring system in which 1 = normal
wall motion, 2 = hypokinesis, 3 = akinesis, and 4 = dyskin-
esis. An LV inducible WMA was defined as an increase in
score of ≥1 (e.g., normal to hypokinetic) in 1 or more
myocardial segments. Segments with an LV wall motion
score of 2 or 3 at rest with no worsening of wall motion
were considered negative for ischemia.
Infarct imaging
Ten minutes after the administration of gadobenate dime-
glumine (Multihance) contrast, late gadolinium enhanced
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precession readout were collected in the same short axis
planes used to assess LV volumes. The sequence parame-
ters included a 6 mm thick slice with a 2 mm gap, an
800 msec TR, a 1.7 msec TE, a 40° FA, a 360 × 270 mm
FOV, and a 192 × 109 matrix with an inversion time ad-
justed to null the myocardium. Enhanced (>3 standard de-
viations in mean signal intensity above background non-
enhanced) regions were identified.
Perfusion imaging
First pass perfusion imaging with gadobenate dimeglu-
mine (0.1 mmol/kg) was performed when 80% MPHRR
was achieved. Eighty percent (80%) of the maximum
predicted heart rate response for age was selected for
this study because [5] this heart rate response was previ-
ously shown to be accurate for identifying ischemia and
forecasting cardiac prognosis [5,14]. A potential benefit
of the mild decrease in peak stress heart rate (80% rela-
tive to 85%), is that it allowed for acquisition of 2 slices
for assessing myocardial first pass perfusion at peak
stress. These perfusion images were collected in the
short axis orientation in the middle and apical segments
(2 slice positions due to the rapid HR). Image parame-
ters included an 8 mm thick slice, a 169 msec TR, a
1.1 msec TE, a FA of 12°, a FOV of 360 × 270 mm and a
192 × 108 matrix. Rest first-pass perfusion imaging was
not performed.
For each LV myocardial segment, a two-step process
was utilized to identify perfusion defects indicative of is-
chemia. First, regions of first-pass hypo-perfusion were
measured as a percentage of the corresponding myocar-
dial wall thickness for that LV myocardial segment in the
same imaging plane (Figure 1). The radial length of the
PD was expressed as a percentage of the total LV myocar-
dial wall thickness. In addition, the duration (or number
of frames) for each PD was calculated from onset of LV
myocardial enhancement until complete resolution of theFigure 1 Discordance between left ventricular wall motion abnormali
ischemia. Cine white blood imaging end-diastolic (left panel) and end-syst
of the left ventricle at peak dobutamine and atropine infusion administered
age. The white arrows indicate normal wall motion of the posterior and lat
enhanced perfusion image also acquired at peak stress is displayed. The ye
consistent with inducible ischemia. This participant underwent contrast cor
saphenous vein graft to the right coronary artery.defect. Any PD that persisted for more than 5 frames from
onset of myocardial enhancement and encompassed >25%
of the thickness of the wall was further evaluated for
classification as ischemic [15]. This criterion of 25% trans-
mural involvement was used successfully by other investi-
gators to exclude dark rim artifacts [16,17].
Further evaluation was performed to exclude PDs re-
lated to prior infarcted territories. The extent of these
PDs suspected of ischemia was compared to the extent
of infarction as assessed in the LGE images within the
same myocardial segments. Participants with PDs that
extended beyond the areas of LGE or occurred in a terri-
tory or segment that differed from the segmental terri-
tory in which the LGE was noted were classified as
ischemic. Any PD that matched the area of LGE was not
classified as ischemic.
Aortic stiffness assessment using pulse wave velocity
According to previously published techniques [18],
PWV was assessed using phase-contrast cardiovascular
magnetic resonance (PC-CMR). Images of the proximal
thoracic aorta were obtained in an axial cross-sectional
plane placed at the apex of the main pulmonary artery
(identified with a sagittal localizer). PC-CMR imaging
parameters included an 8 mm thick slice, a 10 msec TR,
a 3–5 msec TE, a 15-20°FA, 20 ms temporal resolution,
a 340 to 360 mm FOV, a 256 × 192 matrix and a
through plane velocity encoding of 150 cm/sec. Pulse
wave velocity (PWV) was calculated by dividing the dis-
tance between the ascending and descending thoracic
aorta by the transit time of the flow wave [18].
Measures of global myocardial oxygen demand
In addition to the changes in HR, blood pressure (BP) and
the RPP, we also assessed the LV stroke work (SW) and
the systolic PVA, a measure indicating the global LV myo-
cardial oxygen demand [19,20]. The systolic PVA is de-
fined as both the mechanical LV SW and the mechanicalties and perfusion defects indicative of inducible myocardial
olic (middle panel) frames from slice position acquired in the middle
to achieve >80% of the maximum predicted heart rate response for
eral wall segments. However, in the right panel, a first pass gadolinium
llow arrows indicate a hypoperfused region of the LV myocardium
onary angiography which demonstrated a >70% stenosis of the
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This is the area enclosed by the slopes of the end-systolic
and the end-diastolic pressure volume relationship [22].
Invasive studies have shown an excellent correlation
between the PVA and the myocardial oxygen consump-
tion under different loading conditions and with dobuta-
mine. The SW was defined as the mean arterial pressure *
LV stroke volume. The systolic PVA was defined as: LV
SW+ ½* LV end-systolic pressure * end-systolic volume.
LV end systolic pressure was calculated as 0.85* brachial
systolic blood pressure (SBP) [23].
Statistical analysis
In accordance with the American Heart Association
Scientific Statement [24], the 10 middle and apical LV
myocardial segments were assessed for LV first pass PDs,
LGE, and inducible WMA. Participants in this study were
characterized into one of 3 groups including those: 1)
without a PD or WMA (Group I), 2) with a PD but with-
out a WMA (Group II), and 3) with both a PD and a
WMA indicative of ischemia (Group III). The differences
in demographic, hemodynamic, CMR volumetric parame-
ters, and indices of myocardial oxygen demand between
the 3 Groups were assessed by an analysis of variance test
of equality (ANOVA). In Tables 1 and 2, the p-values are
displayed for the overall equality of the three groups. In
the Figures, the comparisons between specific groups
were accomplished using pairwise comparisons. A p-value
of <0.05 was considered significant for either forms of
testing. The differences in the LV myocardial SW and the
PVA were adjusted for preload (resting and peak dose LV
end-diastolic volume index or LVEDVi), afterload (peak
dose PWV), contractility (LV ejection fraction or LVEF),
and LV concentricity using analysis of covariance. Multiple
regression models adjusting for SBP, LVEDV baseline and
LVEDV peak dose were selected and reported by stepwise
regression. The sensitivity and specificity of dobutamine
related wall motion abnormalities for detecting obstruct-
ive CAD was assessed with the results of the perfusion
component of the DCMR protocol serving as the refer-
ence standard. Results were expressed as means ± stand-
ard error of the estimate unless stated otherwise.
Results
Two hundred seventy-eight (278) consecutive partici-
pants were enrolled into the study; the demographic
data from the participants are shown in Table 1. No dif-
ferences in age, gender, BMI, prevalence of hypertension,
diabetes, CAD, dyslipidemia, smoking, or medication
use were noted between the 3 Groups (p = 0.05 to 0.54
for all; Table 1). Analyzing the data using pairwise com-
parisons, there were differences between individuals in
Groups II and III versus those in Group I regarding the
incidence of prior revascularization (32% and 44% vs.13% respectively, p <0.001 for both comparisons); and
prior MI (17% vs. 18% vs. 7% respectively; p = 0.05 for
both comparisons). There were no differences between
Groups II and III regarding the incidence or prior MI or
revascularization (p = 0.98 and p = 0.29 respectively).
According to previously published criteria, 64% of the
participants exhibited LV concentricity and 82% had left
ventricular hypertrophy. Consistent with previously pub-
lished data [25], in the population aged 70 and older,
women compared to men had a greater incidence of
concentric ventricles (80% vs. 42%, p < 0.001 while in
those aged less than 70 there were no gender differences
in the incidence of concentric ventricles (61% vs. 61%,
p =0.87). However women had a higher incidence of
LVH compared to men (96% vs. 62% p < 0.001).
Forty-six participants exhibited a PD indicative of is-
chemia. Of the 46 subjects with PDs, 18 had corre-
sponding inducible LV WMAs (Group III) [13]. The
remaining 28 exhibited a PD but no WMA (Group II).
No participants experienced an inducible LVWMA with-
out a CMR perfusion defect. The presence of a DCMR
inducible LVWMA exhibited a sensitivity of 39% and a
specificity of 100% for the detection of a PD consistent
with inducible LV myocardial ischemia. Example cases
from participants with concordance and discordance be-
tween WMA and PDs are shown in Figures 1 and 2.
Of the 28 patients with perfusion defects consistent
with ischemia in Group II, 6 had peri-infarct ischemia
(i.e. a PD extending beyond proportion to the region of
LGE), 3 had LGE in a different territory and 19 had no
LGE. Of the 18 patients in Group III, 9 had periinfarct
ischemia, 2 had LGE in a different territory and 7 had
no LGE. Compared to the subjects in Group II, those in
Group III trended toward larger trans-mural extents of
their PDs (29% vs. 33%, p = 0.26), somewhat longer dur-
ation PDs (10 frames vs. 13 frames, p = 0.11), and more
segments with LGE (11 vs. 18, p = 0.04). Those in Group
III did exhibit a greater number of WMAs indicative of
ischemia (1 vs. 4, p < 0.001 segments, respectively).
The cardiac chamber volumes and function, arterial
stiffness measures, and hemodynamic parameters of the
participants at rest and with stress are shown in Table 2.
Systolic blood pressure (SBP), diastolic blood pressure
(DBP), pulse pressure (PP), HR and the rate pressure
product (RPP) were similar at rest and with stress
among the 3 Groups (p = 0.22 to 0.77). Overall, with
intravenous dobutamine, the HR rose 96%, the SBP de-
creased 6% and the RPP rose 85% for the participants in
the study with no difference between the three groups
(p = 0.63, 0.74, and 0.92 respectively).
At rest, those in Group I exhibited a higher LVSV
index (LVSVi) and a higher cardiac index compared to
those in Groups II and III (p = 0.03 for both indices).
No differences between the 3 groups were noted in the
Table 1 Demographic data
Category Group I No LV perfusion
defect or wall motion
abnormality (n = 232)
Group II LV perfusion defect
present, no wall motion
abnormality (n = 28)
Group III LV perfusion
defect and wall motion
abnormality present (n = 18)
p-value*
Age (years) 68 ± 8 70 ± 9 69 ± 8 0.32
Men (%) 110 (47%) 14 (50%) 14 (78%) 0.046
Race/Ethnicity 0.50
Caucasian 171 (74%) 23 (82%) 16 (89%)
African Am. 56 (24%) 4 (14%) 2 (11%)
Hispanic 2 (1%) 1 (4%) 0 (0%)
Asian 3 (1%) 0 (0%) 0 (0%)
Body mass index (m/kg2) 30.4 (6.5) 30.3 (4.8) 32.1 (5.4) 0.54
Hypertension 203 (88%) 27 (96%) 16 (89%) 0.38
Coronary artery disease 57 (25%) 9 (32%) 8 (44%) 0.14
Prior MI 16 (7%) 5 (17%) 3 (18%) 0.05
Prior revascularization (PCI or CABG) 31 (13%) 9 (32%) 8 (44%) <0.001
Diabetes 94 (41%) 11 (39%) 8 (44%) 0.94
Hypercholesterolemia 152 (70%) 22 (79%) 12 (86%) 0.30
Smoking 90 (42%) 10 (36%) 6 (43%) 0.79
Medications
Angiotensin converting enzyme inhibitor 99 (43%) 15 (54%) 7 (39%) 0.52
Angiotensin receptor blocker 64 (30%) 5 (18%) 3 (20%) 0.30
Statin 152 (66%) 21 (75%) 14 (78%) 0.37
Beta blocker 99 (43%) 13 (46%) 11 (61%) 0.32
Calcium channel antagonist 68 (30%) 8 (29%) 9 (50%) 0.20
*Analysis of variance test of equality of three groups. Summary statistics are mean (standard error) for continuous variables and frequency (%) for categorical
variables. Abbreviations: CABG, coronary artery bypass grafting; LV, left ventricular; MI, myocardial infarction; PCI, percutaneous coronary intervention.
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rest. Those in Group III possessed the highest concentri-
city index (p = 0.02) compared to those in Groups I and
II with no differences in the LV mass index between the
three groups (p = 0.35). With dobutamine, all three groups
experienced a similar decrease in the LVEDVi. As ex-
pected, individuals in Group III exhibited the lowest stress
LVEF and the highest stress LVESVi values relative to
those in Groups I and II (p = 0.002 and p = 0.001 respect-
ively). PWV was not different among the groups at rest
(p = 0.76) or with stress.(p = 0.14).
The indices of myocardial oxygen demand at rest are
shown in Figure 3 and at stress in Figure 4. At rest as
shown in Figure 3, the left ventricular pressure volume
area (PVA) and stroke work (SW) of individuals in
Group II were lower than those in Group I (9,016 ± 559
vs. 10,439 ± 201 mmHg*ml, p = 0.02 and 6,594 ± 417 vs.
7,794 ± 150 mmHg*ml, p = 0.007 respectively) and lower
than those in Group III (9016 ± 559 vs. 10,618 ±
768 mmHg*ml, p = 0.09 and 6,594 ± 417 vs. 7708 ±
569 mmHg*ml, p = 0.01 respectively). However there were
no differences in PVA and SW between Groups I and II
with dobutamine (7,660 ± 645 vs. 8,409 ± 227 mmHg*ml,p = 0.27 and 6,160 ± 524 vs. 6,877 ± 187 mmHg*ml,
p = 0.25 respectively). In contrast, during stress, the PVA
and SW in Group II were lower when compared to Group
III (7660 ± 645 vs. 10,023 ± 862 mmHg*ml, p = 0.03, and
6,160 ± 524 vs. 7682 ± 715 mmHg*ml, p = 0.09), respectively.
To determine the factors influencing this lower myo-
cardial oxygen demand between groups II and III, we
adjusted the left ventricular PVA and SW for differences
in baseline and peak stress LVEDVi (preload), peak
stress PWV (afterload), the resting LVEF (contractility),
and the LV concentricity as shown in Figure 4A and B
respectively. As shown in Figure 4A, the lower LVPVA
in individuals in Group II relative to Group III persisted
after adjusting for contractility (7,684 ± 649 vs. 10,109 ±
883 mmHg*ml, p = 0.03), and afterload (7,639 ± 682 vs.
10,421 ± 930 mmHg*ml, p = 0.02). However, the differ-
ences in the PVA after dobutamine between individuals
in Groups II and III were eliminated after accounting for
stress LVEDVi (p = 0.71, Figure 4A), and LV concentri-
city (p = 0.31; Figure 4A). Similarly, the lower LVSW in
individuals in Group II relative to Group III persisted
after adjusting for contractility (6,206 ± 529 vs. 8123 ±
720 mmHg*ml, p = 0.03; Figure 4B), and nearly persisted
Figure 2 Concordance between left ventricular wall motion abnormalities and perfusion defects indicative of inducible myocardial
ischemia. Cine white blood imaging end-diastolic (left panel) and end-systolic (middle panel) frames from slice position acquired in the apex of
the left ventricle at peak dobutamine and atropine infusion administered to achieve >80% of the maximum predicted heart rate response for
age. The white arrows indicate a wall motion abnormality in the inferoseptum as manifest by incomplete LV cavity obliteration at peak stress.
In the right panel, a first pass gadolinium enhanced perfusion image also acquired at peak stress is displayed. The yellow arrows indicate a
hypoperfused region of the LV myocardium consistent with inducible ischemia. In this case there was concordance of the wall motion and
perfusion analyses both indicating inducible ischemia.
Table 2 Hemodynamics and CMR indices
Measure Group I (n = 232) Group II (n = 28) Group III (n = 18) p-value*
Rest
Heart rate (beats/min.) 65 (0.74)** 63.64 (2.06) 65.73 (2.81) 0.77
Systolic blood pressure (mmHg) 139.81 (1.18) 137.29 (3.29) 136.67 (4.58) 0.64
Diastolic blood pressure (mmHg) 79.53 (0.82) 75.29 (2.29) 78.80 (3.13) 0.22
Mean arterial pressure (mmHg) 99.58 (0.82) 95.95 (2.27) 98.09 (3.21) 0.30
Rate pressure product 9108 (133) 8753 (369) 8962 (504) 0.65
Left ventricular end diastolic volume index (ml/m2) 62.2 (1.01) 56.7 (2.81) 59.3 (3.91) 0.17
Left ventricular end systolic volume index (ml/m2) 22.2 (0.52) 21.3 (1.31) 22.8 (1.72) 0.72
Left ventricular stroke volume index (ml/m2) 39.4 (0.61) 35.5 (1.52) 36.5 (2.11) 0.03
Ejection fraction (%) 64.2 (0.51) 62.7 (1.41) 62.5 (1.82) 0.46
Cardiac index (ml/min/m2) 2536 (39) 2239 (109) 2380 (149) 0.03
Pulse wave velocity (m/s) 11 (0.47) 9.75 (1.28) 9.96 (1.75) 0.76
Left ventricular mass index (gm/m2) 66 (14) 65.9 (11.32) 71.1 (12.41) 0.35
Left ventricular concentricity 1.09 (0.02) 1.19 (0.05) 1.26 (0.07) 0.02
Stress
Peak heart rate (beats/min.) 127 (1.12) 129.81 (3.16) 126.92 (4.39) 0.63
Peak systolic blood pressure (mmHg) 130 (1.75) 126.37 (4.92) 131.93 (6.84) 0.74
Peak diastolic blood pressure (mmHg) 70.79 (1.21) 68.04 (3.40) 75.14 (4.72) 0.47
Peak mean arterial pressure (mmHg) 90.57 (1.27) 87.48 (3.58) 94.07 (4.97) 0.54
Peak rate pressure product 16400 (251) 16381 (706) 16804 (1982) 0.92
Left ventricular end diastolic volume index (ml/m2) 51.60 (0.78) 50.99 (2.15) 54.97 (2.98) 0.52
Left ventricular end systolic volume index (ml/m2) 13.68 (0.33) 14.53 (0.87) 18.36 (1.24) 0.001
Left ventricular stroke volume index (SVI) (ml/m2) 37.85 (0.62) 36.23 (1.69) 36.64 (2.35) 0.61
Ejection fraction (%) 73.3 (0.50) 71.2 (1.42) 66.5 (1.93) 0.002
Cardiac index (l/min/m2) 4800 (83) 4688 (232) 4644 (316) 0.82
Pulse wave velocity (m/s) 11.51 (0.61) 12.44 (1.69) 16.27 (2.39) 0.14
*Analysis of variance test of equality of three groups. The p-values presented are an overall test that the three groups are equal. Abbreviations:, EDV, End diastolic
volume; EF, Ejection fraction; PVA, Pressure volume area; PWV, Pulse wave velocity; SW, Stroke work.
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Figure 3 Resting measures of myocardial oxygen demand between the three groups. The mean ± the standard error of the myocardial
oxygen demand (Y-axis) and the number of participants in each of the 3 study groups (X-axis) are shown. The myocardial stroke work is denoted
by the gray bars, and the pressure volume area is denoted by the black bars. At rest, Group II participants (wall motion negative, perfusion
positive) have lower myocardial oxygen demand as assessed by myocardial stroke work (SW) than those in III (wall motion and perfusion positive)
or Group I. Also, PVA is reduced in Groups II relative to Group I and trends toward a difference with Group III.
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776 mmHg*ml, p = 0.06; Figure 4B), but as shown in
Figure 4B, were eliminated when adjusted for stress pre-
load, LVEDVi (p = 0.34) and LV concentricity (p = 0.47).
This suggests that the lower LVSW and the PVA seen in
individuals in Group II are related to the LV preload and
LV concentricity. Similar results between Groups II and
III were noted when the PVA and SW were respectively
adjusted for baseline LVEDVI (8,207 ± 555 vs. 9,534 ±
740 mmHg*ml, p = 0.15, and 6,586 ± 459 vs. 7,294 ±
624 mmHg*ml, p = 0.36.
Discussion and conclusions
There are three important findings related to this study.
First, in older men and women receiving a pharmaco-
logic dobutamine stress test, myocardial oxygen demand
often decreases during receipt of intravenous dobuta-
mine despite achieving 80% of the MPHRR for age
(Figure 4A). Second, this reduction in myocardial oxygen
demand is related to altered LV geometry and reductions
in LV preload that are manifested by a decrease in LVEDV
upon receipt of intravenous dobutamine (Figure 4A
and B). Third, dobutamine related reductions in myocar-
dial oxygen demand observed in older men and womenmay confound the identification of LV inducible wall mo-
tion abnormalities indicative of ischemia (Figures 1, 2, 3
and 4). In this study of elderly subjects at risk for inducible
ischemia, of those exhibiting PDs suggestive of ischemia,
60% of individuals did not demonstrate a corresponding
inducible LV wall motion abnormality.
As shown in Figures 1 and 2 and Table 1, we identified
three groups of individuals within the study population:
those without (Group I) or with (Group III) inducible
PDs and WMAs, and those with an inducible PD but
without an inducible LV WMA indicative of ischemia
(Group II). Similar observations in which PDs occur in
the absence of dobutamine induced WMA have been re-
ported in patients with resting LV hypertrophy [26]. In
those with LV hypertrophy, the presence of PDs has an
increased sensitivity when compared to inducible LV
WMA for detection of coronary arterial luminal narrow-
ings of >70% [26]. This is similar to observations made
in studies of patients with altered LV geometry using
both echocardiography and CMR [6,7]. The addition of
myocardial perfusion has previously exhibited diagnostic
and prognostic value with dobutamine stress testing, re-
gardless of whether echocardiography [7,8] or CMR im-
aging [27,28] was used for diagnosis.
Figure 4 (See legend on next page.)
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Figure 4 Adjusted and unadjusted measures of myocardial oxygen demand. A shows the unadjusted differences in myocardial oxygen
demand with stress, specifically the PVA, between Groups II and II. The differences in the unadjusted PVA between Groups II and III are attenuated
when adjusted for LV preload (LV End-diastolic volume (LVEDV)) and LV concentricity, but persist when adjusted for LV afterload (Aortic pulse wave
velocity (PWV) and LV contractility (LV ejection fraction (LVEF). B demonstrates the differences in Stroke work between Groups II and III. Similar to PVA,
LV Preload and Concentricity determine the differences in the Stroke Work between Groups II and III, but not the LV afterload or contractility. A and B
show the attenuation of these differences when adjusted for LV preload and concentricity respectively. This suggests that LV preload and concentricity
are the main factors influencing myocardial oxygen demand.
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sence of WMA, we examined multiple hemodynamic
variables throughout the stress testing procedure. As
shown in Table 2, HR increased while SBP decreased in
all 3 participant groups (Table 2). This decrease in SBP
contrasts with observations in prior studies of younger
individuals in which a hypertensive response was uni-
formly noted after receipt of dobutamine [29]. As a result,
the RPPs of the participants in this study ranged from
16,000 to 17,000 which are somewhat lower values than
reported in previous studies of dobutamine stress testing,
even after accounting for participant age [26,30]. This ob-
servation may be related to the fact that elderly individuals
often exhibit increased ventricular and arterial stiffness.
As a result, their LV end-systolic pressure volume rela-
tionship curve is steeper which can potentially lead to
greater reductions in SBP after the administration of sys-
temic vasodilators when compared to younger individuals
with more compliant arterial systems [30].
PWV, a measure of arterial stiffening, was mildly ele-
vated at rest across the 3 participant Groups. With stress,
PWV remained similar or increased in all 3 Groups with
the largest increase occurring in Group III participants.
These data indicate that overall, aortic stiffness was ele-
vated in older subjects and remained elevated after receipt
of dobutamine. Given the absence of a concomitant in-
crease in SBP in Group III, one possible explanation of
the high PWV is that this group did not experience a
vasodilator response with dobutamine stress. We have
shown that elderly subjects with diabetes and impaired
fasting glucose do not experience a normal decrease in
afterload with dobutamine and instead experience an in-
crease in arterial stiffness as evidenced by a decrease in
aortic distensibility [31].
As shown in Figure 4A, myocardial oxygen demand as
assessed by PVA was diminished at peak stress in those
individuals with PDs but no WMAs (Group II) relative
to those individuals in Group III (p = 0.03). We sought
to determine which aspect (LV preload, LV afterload, LV
contractility, or LV concentricity) of myocardial oxygen
demand accounted for these differences by adjusting for
each variable in our linear regression models. As shown
in Figures 4A and B, after accounting LV preload and
concentricity, the differences in myocardial oxygen de-
mand between Groups II and II were eliminated. Thisimplies that both of these variables were integral for es-
tablishing the difference in myocardial oxygen demand
noted between these two Groups.
Since LV wall motion assessments of ischemia are
driven by a supply–demand mismatch, a lower oxygen de-
mand might not be adequate to provoke a WMA and
could render the study insensitive for the detection of is-
chemia. The observation of a lower myocardial oxygen de-
mand in those with increased LV concentricity, leading to
hyperdynamic (and, consequently, and absence of WMA
even though ischemia may be present during intravenous
dobutamine) has been demonstrated by Mirelis, et al. [32].
These investigators identified fewer DCMR WMA in indi-
viduals with increased LV concentricity.
Consistent with findings from other larger population
based studies such as the Multi-Ethnic Study of Athero-
sclerosis, the elderly individuals in our group exhibited a
smaller LVEDV and increased LV concentricity [28]. In
addition, as reported in other studies, the LVEDVi de-
creased during dobutamine [32]. However, the magni-
tude of the decrease in LVEDVi was higher in this study
relative to observations in prior studies of middle aged
individuals undergoing dobutamine stress [11]. In the
presence of concentric LV remodeling or hypertrophy,
decreases in LV preload can reduce the LV cavity size
and render it more difficult to visualize WMAs even
when myocardial shortening is abnormal [29].
The results of this study have important implications for
the interpretation of dobutamine wall motion stress test-
ing in elderly individuals. As shown in this study, up to
61% of subjects who had ischemia identified by PDs did
not experience an inducible WMA. In addition, the pres-
ence of these PDs was not associated with failure to
achieve target HR during testing, or differences in the SBP
response (which parenthetically decreased during testing)
among all individuals receiving testing. Therefore, indu-
cible ischemia (as defined by an inducible PD) may in fact
be present during dobutamine stress in the elderly even
though LV WMAs are absent. Other studies have found
similar results regarding the lower sensitivity of LVWMA
measures in assessing the risks for CAD [6,28].
Our study does exhibit some limitations. First, we did
not perform contrast coronary angiography on the par-
ticipants. Recently, however, the diagnostic utility and
accuracy of CMR perfusion abnormalities have been
Vasu et al. Journal of Cardiovascular Magnetic Resonance  (2015) 17:26 Page 10 of 11established in multicenter and multivendor trials
[33,34,35]. Second, the majority of our subjects were
Caucasian. Insufficient numbers of individuals from
other ethnicities were present to examine the effects of
race or ethnicity. Third, our study population exhibited
pre-existing CAD and multiple risk factors for CAD with
either no or stable patterns of angina. More research is
required to determine results in subjects with new onset,
or unstable patterns of angina.
In conclusion, despite achieving target HR, a subset of
elderly patients with risk factors for CAD who undergo
dobutamine stress experience perfusion abnormalities
indicative of ischemia without a concomitant LV wall
motion abnormality. Mechanistically, this occurs in part
due to a lower myocardial oxygen demand that appears
related to reductions in LV preload and increases in LV
concentricity.
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